ArticleClinical and translational medicine2023

Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti-programmed death receptor ligand 1 therapy response of triple-negative breast cancer.

Xi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.